Clinical trial Recruiting at 1 site Observational Ages 18 to 50 Women only

Assessing Central Awareness in Women with Endometriosis

Official title: The Role Of Central Sensitisation In Women With Endometriosis: A Prospective Observational Study

Run by IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06773065 · Data updated 2026-11-12

This study is trying to see how common a condition called Central Sensitisation Syndrome is in women with endometriosis and how it relates to their chronic pelvic pain.

Quick facts

Study typeObservational
Ages18 Years to 50 Years
SexWomen only
Enrollment310 (estimated)
SponsorIRCCS Azienda Ospedaliero-Universitaria di Bologna
Academic / other
Locations1 site (Bologna)
StatusRecruiting
StartedJanuary 14, 2022
Main results expectedJanuary 31, 2025
Study endsJanuary 31, 2025
Registry record updatedJanuary 14, 2025
Trial IDNCT06773065 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are women aged 18 to 50 with a clinical, ultrasound, or surgical diagnosis of endometriosis who are starting or currently on hormone therapy.

Probably not a fit

Patients who are post-menopausal, have a history of neurological diseases, or are not compliant with hormone therapy may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to gather information from gynecological examinations and transvaginal ultrasounds to evaluate the prevalence of Central Sensitisation Syndrome (CSS) in women diagnosed with endometriosis. Participants will complete the Central Sensitisation Inventory (CSI) questionnaire to assess the presence and intensity of various clinical symptoms associated with CSS. The study focuses on understanding the relationship between endometriosis and chronic pelvic pain, considering the role of central sensitisation in pain perception. By identifying risk factors and the prevalence of CSS, the study seeks to enhance the understanding of pain mechanisms in women with endometriosis.

Why it matters

Potential benefit: If successful, this study could lead to improved pain management strategies for women suffering from endometriosis.

How similar studies have gone: While the approach of assessing central sensitisation in endometriosis is gaining attention, this specific study's methodology is relatively novel and has not been extensively tested in prior research.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Women with a clinical, ultrasound and/or surgical diagnosis of endometriosis
* Aged between 18 and 50 years
* Patients starting or already taking hormone therapy
* Patients coming for a first visit or outpatient follow-up visit
* Signature of informed consent to participate in the study

Exclusion Criteria:

* Post-menopausal women (spontaneous or iatrogenic)
* Virgo patients
* Patients with poor compliance with hormone therapy, who are not taking it properly or have discontinued therapy spontaneously
* Positive history of any malignant neoplasm
* Positive medical history of specific medical conditions that adversely affect the central nervous system, such as: brain or spinal cord damage, neurological diseases or peripheral nerve damage, multiple sclerosis

Where it's running

  • IRCCS Azienda Ospedaliero-Universitaria di Bologna
    Bologna, Italy
    Recruiting

Study contacts

  • Principal investigator: Diego Raimondo, MD — IRCCS Azienda Ospedaliero-Universitaria di Bologna
  • Study coordinator: Diego Raimondo, MD
  • Email: die.raimondo@gmail.com
  • Phone: +393290636618

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.